This federal Project Grant award, valued at $1,200,000.00 and granted by the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects program (CFDA 11.617), aims to develop the infrastructure to apply a quality-by-design approach for standardizing assay development in the biofabrication industry.
The key activities under this award include simplifying the glucose stimulated insulin secretion (GSIS) assay to make it compatible for automation, determining sources of variability that affect the accuracy of the modified assay, and leveraging subject matter experts to develop a documentary standard and implementation training course. The expected outcome is to provide a simplified, standardized GSIS assay that will improve repeatability and reproducibility, with potential for extrapolation to other cell and tissue-based assays. The award recipient, Advanced Regenerative Manufacturing Institute Inc. (Armi), will not be subawardingfunds under this grant.
Generated 3/25/25, 3:56 AM